Shortcuts

open access

Vol 9, No 2 (2010)
Review articles
Published online: 2010-08-25
Get Citation

Is there enough evidence to advocate opioid combinations? Does one and one make two or more?

Zbigniew Zylicz, Sebastiano Mercadante
Advances in Palliative Medicine 2010;9(2):31-38.

open access

Vol 9, No 2 (2010)
Review articles
Published online: 2010-08-25

Abstract


Despite a more than tenfold increase in opioid consumption in the past decades, many cancer patients still suffer pain. The current understanding of this situation is poorly understood. It is still possible that in some countries pain is still undertreated, but it is also possible that we do not appreciate opioid induced toxicity and other phenomena an/or our opioid prescribing needs to be refreshed. At the moment the only evidence based tool to deal with opioid toxicity is switching to another opioid. Other methods are also described, but are far less well evidenced. However, the effects after switching are short-lived and sometimes a number of switches are needed. In this article we discuss the rationale behind and the possibility of combining different opioids with each other. Opioids are all different and opioid receptors are heterogenous. There are data to suggest that widening the activity spectrum of opioids may be the way forward in order to decrease adverse effects and maintain analgesia. At the moment there are only some data on the interaction of fentanyl and morphine, morphine and oxycodone, and buprenorphine and morphine. These data suggest that we should investigate these problems vigorously and, instead of switching from one opioid to another, we may, in future, adopt the concept of a semi-switch, where the dose of the first opioid is decreased and a second opioid is added.
Adv. Pall. Med. 2010; 9, 2: 31–38

Abstract


Despite a more than tenfold increase in opioid consumption in the past decades, many cancer patients still suffer pain. The current understanding of this situation is poorly understood. It is still possible that in some countries pain is still undertreated, but it is also possible that we do not appreciate opioid induced toxicity and other phenomena an/or our opioid prescribing needs to be refreshed. At the moment the only evidence based tool to deal with opioid toxicity is switching to another opioid. Other methods are also described, but are far less well evidenced. However, the effects after switching are short-lived and sometimes a number of switches are needed. In this article we discuss the rationale behind and the possibility of combining different opioids with each other. Opioids are all different and opioid receptors are heterogenous. There are data to suggest that widening the activity spectrum of opioids may be the way forward in order to decrease adverse effects and maintain analgesia. At the moment there are only some data on the interaction of fentanyl and morphine, morphine and oxycodone, and buprenorphine and morphine. These data suggest that we should investigate these problems vigorously and, instead of switching from one opioid to another, we may, in future, adopt the concept of a semi-switch, where the dose of the first opioid is decreased and a second opioid is added.
Adv. Pall. Med. 2010; 9, 2: 31–38
Get Citation

Keywords

opioids; combinations; interaction of opioids; pain control; morphine; fentanyl; oxycodone; buprenorphine

About this article
Title

Is there enough evidence to advocate opioid combinations? Does one and one make two or more?

Journal

Advances in Palliative Medicine

Issue

Vol 9, No 2 (2010)

Pages

31-38

Published online

2010-08-25

Bibliographic record

Advances in Palliative Medicine 2010;9(2):31-38.

Keywords

opioids
combinations
interaction of opioids
pain control
morphine
fentanyl
oxycodone
buprenorphine

Authors

Zbigniew Zylicz
Sebastiano Mercadante

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl